Search filters

List of works by Amelia McCartney

A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients

scientific article published on 22 March 2018

An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06)

scientific article published on 11 December 2019

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial.

scientific article

Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer

scientific article published on 11 June 2019

De-escalating and escalating treatment beyond endocrine therapy in patients with luminal breast cancer.

scientific article

Early triple negative breast cancer: Are we getting better outcomes? A retrospective analysis from a single institution

scientific article published on 16 July 2019

Estimating the magnitude of clinical benefit from (neo)adjuvant chemotherapy in patients with ER-positive/HER2-negative breast cancer

scientific article published on 01 November 2019

Expanding the Scope of Geriatric Assessment for the Management of Cancer in Older Adults

scientific article published on 07 November 2019

Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?

scientific article published on 10 December 2018

Mechanisms of Resistance to CDK4/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice

scientific article published on 23 July 2019

Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification

scientific article published on 29 August 2019

Metabolomics in breast cancer: A decade in review

article

Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer

scientific article published on 30 November 2020

Neoadjuvant nab-paclitaxel in breast cancer: who stands to benefit?

scientific article published on 03 January 2020

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

scientific article published on 01 August 2018

Palbociclib to reverse endocrine resistance in breast cancer: a TREnd in the right direction?

scientific article published on 25 September 2018

Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial

scientific article published on 14 January 2020

Platinum-based Agent and Fluorouracil in Metastatic Breast Cancer: A Retrospective Monocentric Study with a Review of the Literature

scientific article published on 01 August 2018

Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)

scientific article published on 03 May 2019

The Conundrum of the Association of Chemotherapy With Survival Outcomes Among Elderly Patients With Curable Luminal Breast Cancer

scientific article published on 16 July 2020

The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy

scientific article published on 28 November 2019

The optimal duration of adjuvant endocrine therapy in early luminal breast cancer: A concise review

scientific article published on 25 January 2019

The role of abemaciclib in treatment of advanced breast cancer.

scientific article published on 31 May 2018

Thymidine kinase-1 as a biomarker in breast cancer: estimating prognosis and early recognition of treatment resistance

scientific article published on 07 May 2020